×
Choose Speciality

EXPLORE!

LOGIN

By signing up or signing in to eMediNexus, you consent to eMediNexus collecting and using your personal data in accordance with our Privacy Policy. I consent to receive medical updates and communications from eMediNexus, it's parent company IJCP and its industry partners.

J&J vaccine rollout to resume in Europe with safety warning

  663 Views

eMediNexus    21 April 2021

Johnson & Johnson has stated that it will resume the rollout of its COVID-19 vaccine in Europe after the medical regulator mentioned that the benefits of the vaccine outweigh the risk of very rare, potentially lethal blood clots.

The European Medicines Agency (EMA) has recommended that a warning regarding rare blood clots with low platelet count be added to the vaccine’s product label and stated that the benefits of the single-dose vaccine outweigh its risks.

J&J vaccine rollout was temporarily paused by U.S. regulators last week following reports of rare brain blood clots along with low blood platelet count in six women, which made the company delay its rollout in Europe… (Reuters, April 20, 2021)

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.